TCL Archive Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says September 26, 2014
TCL Archive In Brief: Bleyer To Chair Childrens Cancer Study Group; Fisher To Advise; Penn. Awards Herberman May 3, 1991